CytomX Therapeutics, Inc. Deferred Rent Credit
CytomX Therapeutics, Inc. (CTMX) had Deferred Rent Credit of $200.00 thousand as of 2016-09-30, per its 10-Q filed 2017-11-07.
Discontinued › Balance Sheet › Liabilities
us-gaap:DeferredRentCredit · last filed 2017-11-07
- 2016-09-30: Deferred Rent Credit $200.00K.
- 2016-06-30: Deferred Rent Credit $200.00K; Deferred Rent Credit as first filed $250.00K.
- 2016-03-31: Deferred Rent Credit $2.00K.
| Period end | Deferred Rent Credit | Deferred Rent Credit as first filed |
|---|---|---|
| 2016-09-30 | $200.00K 10-Q · filed 2017-11-07 | |
| 2016-06-30 | $200.00K 10-Q · filed 2017-08-07 | $250.00K 10-Q · filed 2016-08-03 |
| 2016-03-31 | $2.00K 10-Q · filed 2017-05-05 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Monopar Therapeutics (MNPR) | United States | $0.598B | -34.82 |
| Altimmune, Inc. (ALT) | United States | $0.593B | -6.43 |
| CorMedix Inc. (CRMD) | United States | $0.605B | 3.25 |
| Aquestive Therapeutics, Inc. (AQST) | United States | $0.606B | -6.67 |
| IMPACT BIOMEDICAL INC. (IBO) | United States | $0.611B | 66.47 |
| Phathom Pharmaceuticals, Inc. (PHAT) | United States | $0.572B | -8.76 |
| Neurogene Inc. (NGNE) | $0.625B | -4.46 | |
| Shattuck Labs, Inc. (STTK) | United States | $0.634B | -13.30 |
| BlossomHill Therapeutics, Inc. (BLSM) | United States | $0.647B | |
| Indaptus Therapeutics, Inc. (INDP) | United States | $0.537B |